Skip to content
Kalpvruksh Markets
Offline Log in

NEPHROCARENSEOffline

NEPHRO CARE INDIA · INE0SUN01013 · Small Cap · #2300
76.65−0.70 (−0.90%)last close · 05 Nov 2026
Prev close
77.35
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹135 cr

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

NEPHROCARE is a Small Cap company, #2300 by market cap.

ESM · surveillance · our estimateWill NEPHROCARE be put under ESM?
Entry rule met 1-year range — above one standard deviation of companies under ₹1,000 crore and NSE's floor. Stocks newly meeting the rule entered within two weeks 17% of the time; ESM means 100% margin and trade-for-trade.Our estimate, not the exchange’s or the index provider’s. Not advice.

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • FPI −0.2 pp · DII −0.4 pp · no promoter pledge · quarter ended 2026-09-30
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹135 cr
Rank
#2300
Cap band
Small Cap
Nearest cut-off — Mid / Small
−99.60% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.7×
median 14,600
Delivered
25,200
Of volume
67%

Price & trend

Price & trend

Not enough price historyFigures need 60 sessions of NSE prices.

Ownership

Who owns the company

% of all shares, by quarter

GroupSep 25Mar 26Jun 26Sep 26
Promoters61.5%61.7%61.7%61.7%
FPI3.5%0.7%1.0% +0.20.7% −0.2
Mutual funds————
Other DII1.0%1.3%1.3%0.9% −0.4
Individuals27.7%30.3%30.3%31.3% +1.0
Others6.4%5.9%5.7% −0.25.4% −0.3

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Sep 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
1,946
Individuals
1,774

Which funds bought and sold

No fund holds this companyNo Indian mutual fund disclosed a position at the last quarter end.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 1 of 2 disclosures
0 selected
27 Mar 2026Tapas SahaKey Managerial PersonnelBuy9,600₹0.05 cr0.22%Market Purchase

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    10 Aug 2026
  • Board outcome
    Nephro Care India Limited has informed the Exchange regarding Outcome of Board Meeting held on August 07, 2026.
    10 Aug 2026
  • Board outcome
    Nephro Care India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    29 May 2026

NEPHROCARE: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.